Scilex Holding Company 13D and 13G filings for SEMNUR PHARMACEUTICALS, INC. W:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-14 4:01 pm Purchase | 2025-09-22 | 13D | SEMNUR PHARMACEUTICALS, INC. W SMNRW | Scilex Holding Co SCLX | 188,554,849 82.070% | 188,554,849 (New Position) | Filing |
| 2025-09-26 4:10 pm Purchase | 2025-09-22 | 13D | SEMNUR PHARMACEUTICALS, INC. W SMNRW | Scilex Holding Co SCLX | 188,554,849 79.890% | 188,554,849 (New Position) | Filing |